KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Return on Equity (2019 - 2025)

Historic Return on Equity for Takeda Pharmaceutical (TAK) over the last 7 years, with Q3 2025 value amounting to 0.3%.

  • Takeda Pharmaceutical's Return on Equity changed N/A to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year change of. This contributed to the annual value of 0.01% for FY2025, which is 100.0% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Return on Equity stood at 0.3% for Q3 2025.
  • Takeda Pharmaceutical's 5-year Return on Equity high stood at 0.3% for Q2 2025, and its period low was 0.07% during Q2 2023.
  • Over the past 5 years, Takeda Pharmaceutical's median Return on Equity value was 0.12% (recorded in 2024), while the average stood at 0.14%.
  • In the last 5 years, Takeda Pharmaceutical's Return on Equity tumbled by -700bps in 2023 and then surged by 1900bps in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Return on Equity (Quarter) stood at 0.13% in 2021, then decreased by -22bps to 0.1% in 2022, then skyrocketed by 31bps to 0.13% in 2023, then decreased by -12bps to 0.12% in 2024, then surged by 156bps to 0.3% in 2025.
  • Its Return on Equity stands at 0.3% for Q3 2025, versus 0.3% for Q2 2025 and 0.27% for Q1 2025.